Have a feature idea you'd love to see implemented?
Let us know!
IRIX Iridex Corp
Price (delayed)
$1.47
Market cap
$24.27M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.66
Enterprise value
$22.45M
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company's proprietary MicroPulse®
Highlights
Iridex's debt has soared by 82% YoY but it has decreased by 9% from the previous quarter
IRIX's equity has dropped by 68% year-on-year and by 35% since the previous quarter
The quick ratio has dropped by 51% year-on-year and by 18% since the previous quarter
Key stats
What are the main financial stats of IRIX
Market
Valuations
Earnings
Shares outstanding
16.51M
Market cap
$24.27M
Enterprise value
$22.45M
Price to earnings (P/E)
N/A
Price to book (P/B)
5.63
Price to sales (P/S)
0.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.45
Revenue
$49.7M
EBIT
-$10.73M
EBITDA
-$8.83M
Free cash flow
-$5.79M
Per share
Balance sheet
Liquidity
EPS
-$0.66
Free cash flow per share
-$0.36
Book value per share
$0.26
Revenue per share
$3.05
TBVPS
$1.77
Total assets
$31.25M
Total liabilities
$27M
Debt
$2.29M
Equity
$4.25M
Working capital
$8.86M
Debt to equity
0.54
Current ratio
1.55
Quick ratio
0.75
Net debt/EBITDA
0.21
Margins
Efficiency
Dividend
EBITDA margin
-17.8%
Gross margin
40.4%
Net margin
-21.8%
Operating margin
-21.5%
Return on assets
-32.2%
Return on equity
-134.4%
Return on invested capital
-78.3%
Return on capital employed
-71.1%
Return on sales
-21.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRIX stock price
How has the Iridex stock price performed over time
Intraday
-6.96%
1 week
-14.04%
1 month
-25.38%
1 year
-52.58%
YTD
-47.69%
QTD
-16%
Financial performance
How have Iridex's revenue and profit performed over time
Revenue
$49.7M
Gross profit
$20.1M
Operating income
-$10.7M
Net income
-$10.86M
Gross margin
40.4%
Net margin
-21.8%
Iridex's net margin has plunged by 58% YoY
The operating margin has declined by 45% year-on-year
The net income is down by 40% YoY
IRIX's operating income is down by 28% year-on-year but it is up by 2.3% since the previous quarter
Growth
What is Iridex's growth rate over time
Valuation
What is Iridex stock price valuation
P/E
N/A
P/B
5.63
P/S
0.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.45
The EPS has decreased by 38% YoY
The price to book (P/B) is 83% higher than the 5-year quarterly average of 3.3
IRIX's equity has dropped by 68% year-on-year and by 35% since the previous quarter
The stock's price to sales (P/S) is 53% less than its 5-year quarterly average of 1.1 and 35% less than its last 4 quarters average of 0.8
The revenue has declined by 12% year-on-year
Efficiency
How efficient is Iridex business performance
Iridex's ROE has plunged by 179% YoY and by 28% from the previous quarter
The company's return on assets has shrunk by 71% YoY and by 3.2% QoQ
The ROS has shrunk by 58% YoY
IRIX's return on invested capital is down by 47% year-on-year and by 3.7% since the previous quarter
Dividends
What is IRIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRIX.
Financial health
How did Iridex financials performed over time
Iridex's total assets is 16% higher than its total liabilities
The quick ratio has dropped by 51% year-on-year and by 18% since the previous quarter
The company's current ratio fell by 39% YoY and by 10% QoQ
Iridex's debt is 46% less than its equity
Iridex's debt has soared by 82% YoY but it has decreased by 9% from the previous quarter
IRIX's equity has dropped by 68% year-on-year and by 35% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.